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Abstract
Background: Resistance Nodulation Division (RND) efflux pumps of Escherichia coli extrude antibiotics and toxic substances
before they reach their intended targets. Whereas these pumps obtain their energy directly from the proton motive force
(PMF), ATP-Binding Cassette (ABC) transporters, which can also extrude antibiotics, obtain energy from the hydrolysis of
ATP. Because E. coli must pass through two pH distinct environments of the gastrointestinal system of the host, it must be
able to extrude toxic agents at very acidic and at near neutral pH (bile salts in duodenum and colon for example). The herein
described study examines the effect of pH on the extrusion of ethidium bromide (EB).
Methodology/Principal Findings: E. coli AG100 and its tetracycline induced progeny AG100TET that over-expresses the
acrAB efflux pump were evaluated for their ability to extrude EB at pH 5 and 8, by our recently developed semi-automated
fluorometric method. At pH 5 the organism extrudes EB without the need for metabolic energy (glucose), whereas at pH 8
extrusion of EB is dependent upon metabolic energy. Phe-Arg b-naphtylamide (PAbN), a commonly assumed inhibitor of
RND efflux pumps has no effect on the extrusion of EB as others claim. However, it does cause accumulation of EB.
Competition between EB and PAbN was demonstrated and suggested that PAbN was preferentially extruded. A Km
representing competition between PAbN and EB has been calculated.
Conclusions/Significance: The results suggest that E. coli has two general efflux systems (not to be confused with a distinct
efflux pump) that are activated at low and high pH, respectively, and that the one at high pH is probably a putative ABC
transporter coded by msbA, which has significant homology to the ABC transporter coded by efrAB of Enterococcus faecalis,
an organism that faces similar challenges as it makes its way through the toxic intestinal system of the host.
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Introduction
Bacteria that are orally ingested need to survive when exposed
to noxious agents such as toxic bile salts that are present along the
digestive tract (ex: duodenum and colon). Resistance of Gram-
negative bacteria to bile salts has been attributed to the presence of
an efflux pump, which extrudes the agent prior to its reaching
sensitive and lethal targets within the bacterium [1-4]. With
respect to E. coli, extrusion of noxious agents is performed
primarily by the AcrAB efflux pump, although other efflux pumps
may assist in the extrusion process [5]. Collectively, these efflux
pumps are classified as belonging to the Resistance Nodulation
Division (RND) family of transporters [6,7]. RND efflux pumps
are tripartite units that consist of a TolC protein connected to the
transporter protein and provides the conduit for the passage of the
exported agent to the outside of the bacterium [8]. The
transporter component of the pump is anchored to the plasma
membrane of the bacterium by two flanking fusion proteins. The
tripartite pump obtains the necessary energy to power extrusion of
the agent directly from the trans-membrane proton gradient
[9,10]. This gradient provides the protons that are present in the
periplasmic space and, when they enter the transporter at its
PLoS ONE | www.plosone.org 1 August 2009 | Volume 4 | Issue 8 | e6656plasma membrane base, they energize the pump and the agent
which is believed to be concentrated within the outer leaflet of the
inner membrane is in turn extruded [11]. The proton is then
released to the medial side of the plasma membrane. The fusion
proteins are believed to physically assist the extrusion of the agent
[11].
The proton motive force (PMF) is in part established by protons
generated following the hydrolysis of ATP catalyzed by membrane
bound ATPases [12–16] and by oxidative metabolism [17]. The
generation of these protons takes place at sites medial to the inner
membrane of the Gram-negative bacterium. After the protons are
exported to the periplasm by a variety of transport processes, most
of which are then exported to the surface of the cell, the
distribution of protons between the periplasm and the cell surface
results in a proton gradient that is greatest at the surface of the cell
and least in its periplasm. This distribution establishes a relative
negative charged periplasmic space and positive charged surface of
the cell and results in an electrochemical gradient. The resulting
trans-membrane difference in the electrochemical potential of
hydrogen ions was at first seen to be the driving force behind the
energy consuming enzymes and ATP-synthase and was defined as
the proton motive force (PMF) [18]. However, because of the
largesse of the bulk water phase the dissemination of protons from
the surface of the cell would quickly eliminate the pH gradient
across the cell envelope, and hence, the PMF and the energy it
provides for driving efflux pumps would be eliminated [18].
Because the PMF is maintained by the bacterium when challenged
by changes in the pH of the environment [19,20] the
chemiosmotic theory required revision, and the concept was
extended to include the distribution of protons on the surface of
the cell which due to the components of the outer cell envelope,
would be selectively concentrated and result in a pH of the
medium immediately surrounding the surface of the cell that
would be much lower than the pH of the bulk medium [21]. This
surface distribution of protons therefore assists the bacterial cell in
maintaining a PMF that would not be significantly affected by the
pH of the medium [22]. Consequently, it is widely held that the
pH of the medium should not affect the activity of a RND efflux
pump even though there is no evidence in support of this
conclusion. Exposure of Salmonella to low pH is well known to
activate the PmrA/PmrB two component regulatory system which
not only allows the organism to survive the low pH of the
phagolysosome, but also increases its resistance to antibiotics [23].
Exposure of E. coli to low pH activates a wide spectrum of genes,
some of which code for cell envelope proteins [24,25]. These
studies suggest that low pH readily activates genes of a Gram-
negative bacterium and render the organism resistant. Although
the question of whether pH-induced resistance of a Gram-negative
involves the activation of genes that regulate and code for efflux
pump constituents remains our goal, we have asked the question of
whether pH has a direct effect on the RND efflux pump AcrAB of
E. coli. We herein report that pH significantly modulates the efflux
of the known efflux pump substrate ethidium bromide (EB) and
correlate this modulation to the challenges that the organism faces
when it passes through regions of the intestinal system that differ
significantly in pH and yet present the same toxic challenges.
Results
Because pH affects many activities of the cell envelope surface
that affect the growth of E. coli [26,27], the effect of pH on the
growth of the E. coli AG100 and AG100TET was determined.
Briefly, as evident from Table 1, the calculated slopes depicting
rate of growth, indicate that both strains grow more slowly at pH 5
than at pH 7. However, the rate of growth is twice as slow for the
AG100TET as opposed to that of the parental strain AG100.
Nevertheless, whereas movement through the low acid compo-
nents of the digestive tract does not significantly effect the survival
of the organism, the presence of toxic agents such as bile salts in
the small and large intestine, poses problems of survival if these
agents permeate into the bacterium.
The ability of each strain to extrude different concentrations of
EB were verified by using a 96-well microplate containing Tryptic
Soy broth (TSB) with increasing concentrations of EB as described
by Figure 1. The assay, performed at pH 5 and 8, indicates that
AG100TET begins to fluoresce in medium at pH 8 at a
concentration of 0.6 mg/L of EB, whereas the wild-type AG100
begins to fluoresce at 0.2 mg/L of EB. This difference is in
accordance to the degree of AcrAB efflux pump expression,
namely the AG100TET over-expresses this pump 6-fold over that
of AG100, as shown by real-time quantitative reverse transcrip-
tase-PCR (qRT-PCR) [5]. At the lower pH, the strains require
higher concentrations of EB to fluoresce: 1.5 and 0.6 mg/L for the
AG100TET and AG100, respectively.
Accumulation of EB by AG100 in glucose-free saline and the
effect of pH are shown in Figure 2A. Whereas no significant
accumulation of EB takes place in glucose-free saline pH 5,
accumulation of EB in glucose-free saline at pH 8 takes place
during the first 25 minutes. The need for metabolic energy at
pH 8 for efflux of EB is illustrated with the addition of glucose to
the cells after 25 minutes of accumulation of EB in glucose-free
saline at pH 8, inasmuch as the amount of fluorescence drops and
is maintained at the initial level noted at the beginning of the
accumulation period. The addition of glucose-free saline at pH 8
does not affect the rate of EB accumulation noted during the
accumulation period of the assay. These results clearly demon-
strate the activity of the intrinsic efflux pump system of the wild-
type E. coli AG100 strain that is operating at pH 8. At pH 5, it is
assumed, at this time, that the reason for little or no accumulation
of EB regardless of metabolic energy (glucose) is due to the activity
of the PMF dependent RND efflux pump.
Accumulation and efflux of EB by the AG100TET strain, that
over-expresses the AcrAB efflux pump, compared to AG100
[5,25], and the need for metabolic energy for efflux at pH 8 and
not at pH 5 is similarly demonstrated by Figure 2B.
The demonstration of an RND type efflux pump of a Gram-
negative is usually conducted with the PMF un-coupler carbonyl
cyanide m-chlorophenylhydrazone (CCCP) at pH 7 and in the
absence of metabolic energy. Given the demonstration that at
pH 8 metabolic energy optimizes efflux, the activity of varying
concentrations of this agent at pH 5 and 8 on the efflux of EB after
the fluorochrome has accumulated in the absence of glucose has
been studied and the results obtained described by Figure 3 for
the AG100TET that over-expresses its AcrAB efflux pump [5,25].
At pH 5 and 8, CCCP immediately prevents efflux and increases
Table 1. The growth rates of E. coli AG100 and AG100TET in
MH at pH 5, 7 and 8.
E. coli strain Slope at pH 5 Slope at pH 7 Slope at pH 8
AG100 0.22 0.40 0.29
AG100TET 0.06 0.22 0.19
Legend: Growth rates are presented as slopes which are calculated from the
number of hours of culture divided into the total optical density (OD at 600 nm)
of the culture. The steeper the slope the faster the growth rate.
doi:10.1371/journal.pone.0006656.t001
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dependent manner. However, comparison of the slopes of
accumulation between that at pH 5 and pH 8 indicates that at
pH 8 the effect of CCCP is considerably greater. Because these
assays were conducted at the same time and under the same
conditions other than pH, the lesser effects of CCCP at pH 5 may
be due to the large contribution of protons at pH 5 that exceeds
the proton binding capacity of the CCCP concentration. At pH 8,
due to a far lower concentration of available protons, the
concentration of CCCP essentially binds all of the protons and
thereby it completely inhibits efflux of EB. The same effects were
produced by CCCP and its modulation of EB efflux by the
intrinsic efflux pump system of the AG100 wild-type strain (data
not shown). The observation that CCCP promotes the retention of
EB at pH 5 demonstrates that the much lower accumulation of EB
at this pH is due to efflux as opposed to a decrease of permeability
to EB.
Phe-Arg b-naphtylamide (PAbN) has been used to demonstrate
the presence of an active efflux pump that renders some Gram-
negative bacteria resistant to given antibiotics. This demonstration
involves the reduction of a minimum inhibitory concentration
(MIC) of a given antibiotic over a 16 hour culture. However, our
previous studies suggested that PAbN is not an inhibitor of an
efflux pump but rather a competitor of other efflux pump
substrates for extrusion [25], a suggestion also made by others
[26]. This postulated preferential extrusion of PAbN is believed to
result in the increased concentration of the antibiotic which
eventually reaches a level that inhibits the replication of the
organism. Moreover, if PAbN is an inhibitor of an RND efflux
pump, then it should inhibit the efflux of EB at pH 5 inasmuch as
the efflux of EB at pH 5 is independent of metabolic energy and
dependent upon the PMF. The effect of PAbN on the
accumulation and efflux of EB by the AG100TET at pH 5 is
described by Figure 4. As evident from this figure, the addition of
PAbN has no effect on the efflux of EB at either pH. However,
because PAbN competes with EB, as the concentration of PAbNi s
increased, more and more EB would be expected to accumulate.
This anticipated relationship was exploited for the derivation of a
Km for PAbN relative to EB at pH 5 inasmuch as at this pH
metabolic energy is not needed and PAbN has no effect on efflux
of EB. Moreover, the dissociation constant of EB from the AcrB
transporter is lowest at pH 5 [28], a condition that is necessary for
continuous efflux of EB. As described by the composite Figure 5,
as the concentration of PAbN is increased from 1 to 40 mg/L, the
amount of EB accumulation is proportionately increased.
Employing Michaelis-Menten formulae, the Km for PAbN
representing competition between PAbN and EB was calculated
to be 4.21 mg/L.
Figure 1. Fluorescence of the strains E. coli AG100 and AG100TET in EB containing media at pH 5 and pH 8. From the left to the right,
the fluorescence emitted by the bacteria grown in decreasing concentrations of EB during 16 hours. The controls of the media (TSB with or without
EB) at pH 5 and pH 8 are presented in the last four rows of the plate.
doi:10.1371/journal.pone.0006656.g001
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[29] and mycobacteria [30]. However, there is little information
regarding the effects of verapamil on efflux activity of a Gram-
negative such as E. coli. Considering the possibility that the study
of agents for inhibitory activity against efflux pumps is always
conducted at neutral or near neutral, and because at pH 8 efflux
of EB by the E. coli s t r a i n se m p l o y e di nt h i ss t u d yi sd e p e n d e n t
upon metabolic energy, suggesting the involvement of an ABC
type transporter, we have evaluated the effects of concentrations
of verapamil on efflux of EB. As evident by Figure 6,a n d
consistent with previously presented data, at pH 8 efflux of EB
is dependent upon the presence of metabolic energy. The
addition of verapamil in the absence of metabolic energy,
promotes a concentration dependent inhibition of efflux which
causes proportional increases in accumulation of EB. The
inhibitory effect on efflux by verapamil is significantly decreased
when metabolic energy is present. These results suggest that at
pH 8, efflux of EB is at the very least, partially conducted by an
Figure 2. The effect of pH and the need for metabolic energy for efflux of EB by E. coli AG100 (Fig. 2A) and AG100TET (Fig. 2B).
Accumulation of EB in glucose-free saline at pHV5 and 8 for 25 minutes. Instrument is stopped and glucose-free and glucose-saline pHV5 and 8,
respectively, is added and the instrument restarted. A slight drop of recording takes place when the instrument is stopped and when restarted
measurement of fluorescence continues. Note. Whereas the addition of glucose-saline at pH 8 to the tube containing glucose-free saline at pH 8
causes an immediate drop of fluorescence, the addition of glucose-free medium does not, and the slope representing the increase of fluorescence
remains equal to that exhibited during accumulation in glucose-free saline at pH 8. Accumulation of EB in glucose-free saline at pH 5 is minimal (just
above background) and remains unaltered with the addition of either glucose-free or glucose-saline at pH 5.
doi:10.1371/journal.pone.0006656.g002
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AG100TET strain (data not shown).
Discussion
The results presented in this study demonstrate that the pH of
the milieu modulates the over-all activity of the intrinsic and over-
expressed efflux pump system of E. coli. pH modulation of genes
that code for ion transporters of E. coli has been previously
demonstrated by others [31]. However, this is the first time that
pH is shown to modulate the accumulation and extrusion of an
efflux pump substrate such as EB.
The effect of pH on the cell envelope, its constituents, genes that
regulate growth and metabolism has been reported and reviewed
in detail [31]. As also shown in the current study, low and high pH
reduces optimum growth demonstrable at pH 7. However, low
pH is not a problem for E. coli inasmuch as its survival, regardless
of a slower growth rate, is not significantly affected as evident from
Figure 3. Effect of CCCP concentrations on efflux of EB by E. coli AG100TET at pH 5 and 8. The same protocol of accumulation was
followed as for Figure 2. After 25 minutes, saline with glucose and CCCP was added to the tubes. The control without CCCP and without glucose is
also presented.
doi:10.1371/journal.pone.0006656.g003
Figure 4. Effects of PAbN on efflux of EB by AG100TET at pH 5 and 8. The same protocol of accumulation was followed as for figure 2. After
25 minutes media with glucose and PAbN was added to the tubes.
doi:10.1371/journal.pone.0006656.g004
pH Modulation of Efflux
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colonizing the colon. The survival of the organism is dependent
upon its ability to extrude noxious agents present in the digestive
system of the host. Clearly, the ability to extrude a noxious agent is
intrinsically present in wild-type E. coli. The extrusion capability
when over-expressed, make therapy of multi-drug resistant (MDR)
E. coli infections problematic.
The selection of pH affords the distinction between an efflux
pump system immediately dependent on the PMF, such as a RND
efflux pump, and one that is dependent upon metabolic energy
and inhibited by verapamil. Because the msbA gene of E. coli is
similar to the ABC transporter gene efrAB of E. faecalis [32,33], we
believe that the glucose dependent efflux at pH 8 noted in our
study may be conducted by the putative MsbA transporter.
Further studies have to be performed in order to identify the ABC
transporter in this study. Nevertheless, an ABC type transporter
system that has the capability to extrude the efflux pump substrate
EB has now been demonstrated for the first time in E. coli.
The current study utilizes a modification of the semi-automated
fluorometric method previously described [34]. Firstly, whereas in
the initial method a pH of 7 was maintained for the entire study,
the current method utilizes a range of pH and glucose-free saline
for the EB accumulation phase. Secondly, whereas the initial
method employed a wash for the removal of EB, the medium
replaced with EB free-saline, and the efflux of EB was then
followed, in the current method after the accumulation phase,
glucose-saline of matching pH is added and, in accordance to the
criteria governing the source of energy driving the pump, efflux of
EB is followed. This simple change in the method makes it far less
cumbersome, eliminates the possibility of leakage of EB due to the
washing procedures and the large variation between replicates due
to the wash, and perhaps of greatest importance, the rate of efflux,
almost from the very beginning can be noted. We say ‘‘almost’’
because the stopping of the instrument after the EB accumulation
phase, the additions and their number, the return of the samples to
the instrument and restarting the instrument introduce a variable
of time during which the addition of glucose is immediately
followed by efflux of EB. However, in our hands, this time variable
did not exceed 2.5 minutes when as many as 12 individual
additions were made, and did not produce any qualitative
variation between replicate runs.
Our results also indicate that the widely used efflux pump
substrate PAbN is not an inhibitor of the efflux pump as previously
suggested by others [26], and that the initial evidence provided in
support of this contention [32] has now been verified by the
current study. Furthermore, the degree of competition between
Figure 5. Competition between EB and PAbN: calculation of Km for PAbN relative to EB. Increasing concentrations of PAbN from 1 to
40 mg/L caused increase of fluorescence (A). This data was then used for the derivation of the PAbNK m initially plotted by (B) and data employed in
the Michaelis-Menten (C).
doi:10.1371/journal.pone.0006656.g005
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demonstrated and has resulted in a Km for PAbN relative to EB of
4.21 mg/L.
Our study supports the contention that the survival of a
bacterium as it makes its way through the digestive system and
eventual colonization of the colon, is assured by the activity of two
types of efflux pump systems: one that operates directly from PMF
derived energy and the other from a putative ATP binding
transporter. It is supposed that when the bacterium reaches the
duodenum, the toxicity presented by high concentrations of bile
salts must be obviated and this is accomplished by the extrusion of
these toxic substances by an RND efflux pump such as the AcrAB
of E. coli. Because our study demonstrates that the intrinsic efflux
pump system of wild-type E. coli is perfectly capable of extruding
EB in glucose-free saline at pH 5, and this extrusion can be
eliminated by a un-coupler of the PMF, it should be this PMF
dependent pump system which protects the bacterium while
passing through the duodenum. There is no need for an over-
expressed PMF dependent efflux pump system. When the
organism reaches the colon, bile salts, as well as many secreted
agents produced by the normal flora, are present and are toxic to
the organism. The pH of the colon is near 7 and because of the
scarcity of protons in this bulk medium the concentration of
surface bound protons must be affected, and is probably much
lower than that at pH 5. If the RND pump is to operate under
these conditions, the PMF must be maintained and the protons
needed to activate the RND efflux pump must be available in the
periplasm [11]. Subsequent to the extrusion of the noxious agent
the protons are released to the cytoplasm. Two general situations
are expected from the activity of the RND efflux pump at pH 7 or
higher: firstly, the consumption of protons from the periplasm
reduces the PMF unless protons are replaced from the surface of
the cell. The process of replacement is probably limited and
inadequate for the maintenance of an RND efflux system under
these conditions; secondly, the release of protons to the medial side
of the cytoplasm membrane will decrease the pH and the synthesis
of ATP by ATP-synthase is favoured [34,35]. The utilization of
protons for the synthesis of ATP insures that the pH gradient
between the periplasm and cytoplasmic side of the plasma
membrane is maintained. The ATP generated is then bound by
the ABC transporter, hydrolyzed and the energy from this process
activates the ABC transporter to extrude the noxious agent.
Metabolic energy also contributes to this process. In the toxic
environment of the colon, we suppose the organism receives
protection from the ABC type efflux pump system that relies
primarily on metabolic energy, energy that is derived from the
richness and practically unlimited supply of carbohydrates
continuously replenished by the digestive processes of the human
host.
The demonstration of pH modulated efflux pump activity is
extremely significant for the design of agents that are to serve as
efflux pump inhibitors (EPIs). If the agent is to be an effective
adjuvant to antibiotic therapy for the management of a food-borne
infection caused by an efflux mediated MDR Gram negative
bacterium such as an E. coli strain, it must be active against the
ABC transporter that is protecting the bacterium from the toxic
agents of the colon, and during antibiotic therapy. EPIs whose
effectiveness is shown against RND type efflux pump systems may
not be effective in the environment in which the offensive
bacterium resides. Consequently, an EPI that is to serve as an
adjunct to antibiotic therapy aimed at an efflux mediated MDR
coliform infection should be evaluated for activity under
physiological conditions, namely at a pH that favours the activity
of ABC type efflux pump systems.
Materials and Methods
Materials
Media. Mueller-Hinton (MH) and Tryptic Soy in powder
form for the preparation of broth and agar were purchased from
Oxoid Ltd. (Basingstoke, UK). Phosphate buffered saline, glucose.
tetracycline, EB, CCCP, PAbN and verapamil, purchased from
Sigma-Aldrich Quı ´mica SA (Madrid, Spain).
Bacteria. Wild-type E. coli K-12 AG100 strain (argE3 thi-1
rpsL xyl mtl delta (gal-uvrB) supE44) [24], was kindly offered by
Figure 6. The effects of concentrations of verapamil (VP) on the efflux of EB by AG100 at pH 8.
doi:10.1371/journal.pone.0006656.g006
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This strain, sensitive to tetracycline (MIC of 2 mg/L) was exposed
to increasing concentrations of tetracycline. The resulting strain
AG100TET is resistant to 8 mg/L tetracycline (MIC of 12 mg/L)
and to other antibiotics of unrelated classes [5,25]. This strain
subsequently transferred to drug free medium or to medium
containing 8 mg/L tetracycline and the EPI PAbN assumes initial
susceptibility to tetracycline of 2 mg/L [5,25].
Methods
The effect of pH on the growth of E. coli AG100 and
AG100TET. MH medium at pH 5, 7 and 8 (10 mL) was
inoculated with 0.1 mL of an overnight culture and incubated at
37uC with shaking at 220 rpm until stationary phase. The OD of
the culture at the end of incubation was divided by the number of
hours for that culture to reach stationary phase. This calculation
provides a ‘‘Growth Rate’’, reflected by the slope of the growth
curve: the steeper the slope (higher rate) the faster the growth.
Determination of minimum inhibitory concentrations
(MICs). MICs of PAbN, CCCP and verapamil against the
strains employed in this study was conducted in MH medium
adjusted to pH 5, 6, 7 and 8 by the broth microdilution method as
per CLSI guidelines [5]. These MICs were performed for the
purpose of selecting concentrations of these agents that have no
significant effect on the growth of the strains used. The
concentration of each agent employed did not exceed J of its
MIC.
Evaluation of efflux activity by a 96-well microplate
screening method. The method that evaluates the ability of
a bacterial strain to handle EB, that is, extrude EB, has been
previously described [36] via an EB agar method. The principles of
this method have been retained in a new assay that assesses the
ability of a bacterial strain to extrude EB. This new assay employs
a 96-well microplate in the manner employed for the
determination of MICs. Briefly, varying concentrations of EB in
TSB of varying pH were added to the wells after which time an
inoculum of bacteria corresponding to a 0.5 McFarland was
added. The plates were incubated for 16 hours and the lowest
concentration of EB that promotes fluorescence of the contents of
the well recorded and the plates photographed under UV light in a
Gel-doc XR transiluminator (Bio-Rad, Hertfordshire, UK).
Assessment of putative efflux pump activity of E. coli
AG100 and AG100TET by a semi-automated fluorometric
method. Detection of efflux pump activity in E. coli AG100 and
AG100TET was conducted by a semi-automated fluorometric
method, previously described by us [34]. However, we have
introduced a modification that affords the evaluation of efflux
without the need to centrifuge for the removal of EB. This
modification is described in the section that evaluates efflux of EB
after addition of glucose or of agents that are being evaluated for
activity against efflux of EB.
For the assessment of accumulation of EB and conditions that
affect it the following was performed. Briefly, strains were cultured
in MH broth medium until they reached an OD of 0.6 at 600 nm
and aliquots of 1.0 mL were centrifuged twice at 13,000 rpm for 3
minutes. The pellets were re-suspended in saline and the OD
adjusted to 0.6 in saline of pH 5, 7 and 8. Aliquots of 0.045 mL
were transferred to microtubes of 0.2 mL and 0.045 mL of EB in
glucose-free saline of pH 5, 7 and 8 added to the respective tubes
(same pH). The final concentration of EB for all experiments was
1.0 mg/L. Concentrations of EB much greater than 1.0 mg/L
exceed the ability of the cell to extrude the agent, the level of
intracellular agent rapidly increases and results in its intercalation
between the nucleic bases of DNA. EB when bound to DNA is no
longer available for extrusion [25]. The tubes were transferred to
the Rotor-Gene
TM 3000 thermocycler (Corbett Research, Sydney,
Australia) programmed for 30–40 cyles of 1 minute (approximately
30–40 minutes) at a constant temperature of 37uC. Accumulation
of EB of each tube was followed on a real-time basis by the
assessment of fluorescence emitted. Excitation and emission
wavelengths were 530 nm (bandpass) and 585 nm (highpass),
respectively. Whereas the medium containing 1.0 mg/L of EB
does not appreciably fluoresce, as the concentration of EB builds
up in the periplasm of the Gram-negative bacterium, fluorescence
is readily detected by the instrument [34].
The assessment of efflux of EB at pH 5, 7, and 8 was conducted
as follows: accumulation of EB at pH 5, 7 and 8, as described
above, was first conducted for up to 25 minutes, after which time
the instrument was stopped and 0.010 mL of saline at pH 5, 7 and
8 lacking and containing glucose to yield a concentration of 0.4%
was added to the respective tubes. The tubes were then transferred
to the instrument and the instrument re-started. The total amount
of time between this addition and the time the instrument was re-
started did not exceed 2.5 minutes. Fluorescence was followed for
a minimum period of 10 minutes. Data presented is for pH 5 and
8; at pH 6 and 7 data is intermediate between the ranges of pH
and is not shown.
The effects of varying concentrations of CCCP, PAbN and
verapamil on the efflux of EB was carried out as follows:
accumulation of EB in glucose-free saline at pH 5, 7 and 8 was
conducted as described above and when the plateau of
accumulation was reached, the instrument was stopped and
0.045 ml of glucose-saline at pH 5, 7 and 8 containing varying
concentrations of CCCP, PAbN and verapamil was added to the
respective tubes. The tubes were placed into the instrument, the
instrument re-started and fluorescence followed for up to 15
minutes. The total time for these additions did not exceed 2.5
minutes. For some experiments, the addition of CCCP at varying
concentrations was in matched pH glucose-free medium. This
component of the experiment afforded an additional control that
would define any role of metabolic energy in conjunction with any
effect produced by given concentrations of CCCP on efflux of EB
and the modulation of efflux at a given pH.
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